Premium
Pleiotropic Effects of Chronic Phorbol Ester Treatment to Improve Glucose Transport in Insulin‐Resistant Cardiomyocytes
Author(s) -
Viglino Christelle,
Khoramdin Bahareh,
Praplan Guillaume,
Montessuit Christophe
Publication year - 2017
Publication title -
journal of cellular biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 165
eISSN - 1097-4644
pISSN - 0730-2312
DOI - 10.1002/jcb.26139
Subject(s) - protein kinase c , rottlerin , glucose transporter , medicine , endocrinology , glucose uptake , chemistry , insulin , stimulation , phorbol , autophosphorylation , biochemistry , kinase , protein kinase a , biology
Stimulation of glucose transport is an important determinant of myocardial susceptibility to ischemia and reperfusion. Stimulation of glucose transport is markedly impaired in cardiomyocytes exposed to free fatty acids (FFA). Deactivation of the Focal Adhesion Kinase (FAK) by FFA contributes to glucose transport impairment, and could be corrected by chronic treatment with the phorbol ester TPA. However, TPA must have effects in addition to FAK reactivation to restore stimulated glucose transport. Chronic treatment with TPA improved basal and stimulated glucose transport in FFA‐exposed, but not in control cardiomyocytes. Chronic FFA exposure induced the activation of PKCδ and PKCϵ. TPA markedly downregulated the expression of PKCα, PKCδ, and PKCϵ, suggesting that PKCδ or PKCϵ activation could contribute to inhibition of glucose transport by FFA. Rottlerin, a specific PKCδ inhibitor, improved glucose transport in FFA‐exposed cardiomyocytes; and PKCδ was reduced in the particulate fraction of FFA + TPA‐exposed cardiomyocytes. TPA also activated Protein Kinase D 1(PKD1) in FFA‐exposed cardiomyocytes, as assessed by autophosphorylation of PKD1 on Y916. Pharmaceutical inhibition of PKD1 only partially prevented the improvement of glucose transport by TPA. Chronic TPA treatment also increased basal and stimulated glycolysis and favored accumulation of lipid droplets in FFA‐exposed cardiomyocytes. In conclusion, basal and stimulated glucose transport in cardiomyocytes is reduced by chronic FFA exposure, but restored by concomitant treatment with a phorbol ester. The mechanism of action of phorbol esters may involve downregulation of PKCδ, activation of PKD1 and a general switch from fatty acid to glucose metabolism. J. Cell. Biochem. 9999: 4716–4727, 2017. © 2017 Wiley Periodicals, Inc.